
Vimian Group reports 7% miss in Q2 adjusted EBITA
Investing.com -- Vimian Group AB (STO:VIMIAN) reported second-quarter results below expectations, with adjusted EBITA of EUR 25.4 million, missing analyst consensus by 7%. The animal health company posted net sales of EUR 104.3 million, up 15% year-over-year but 2% below Modular Finance consensus estimates. The revenue miss was primarily due to weaker-than-expected performance in the Specialty Ph ...